Medicare Negotiation's Drug Reformulation Problem.
作者信息
Vogel Matthew, Rome Benjamin N, Kesselheim Aaron S, Feldman William B
机构信息
John F. Kennedy School of Government, Harvard University, Cambridge, Massachusetts (M.V.).
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (B.N.R., A.S.K.).
出版信息
Ann Intern Med. 2024 Jun;177(6):817-819. doi: 10.7326/M24-0138. Epub 2024 Apr 30.
DOI:10.7326/M24-0138
PMID:38684103
Abstract
摘要
相似文献
1
Medicare Negotiation's Drug Reformulation Problem.医疗保险谈判中的药品重新配方问题。
Ann Intern Med. 2024 Jun;177(6):817-819. doi: 10.7326/M24-0138. Epub 2024 Apr 30.
2
Is It Working? Evaluating The First Round Of Medicare Drug Price Negotiations.医保药品价格首轮谈判效果如何？
Health Aff (Millwood). 2024 Sep;43(9):1206-1208. doi: 10.1377/hlthaff.2024.00994. Epub 2024 Aug 13.
3
How insurers' bargaining power affects drug prices in Medicare Part D.保险公司的议价能力如何影响医疗保险D部分的药品价格。
Natl Bur Econ Res Bull Aging Health. 2009(4):1-2.
4
Lowering Part D drug costs without direct CMS negotiations.在没有医疗保险和医疗补助服务中心（CMS）直接谈判的情况下降低D部分药品成本。
Manag Care. 2009 Sep;18(9):11-2.
5
'Negotiating' drug prices for Medicare.
Healthc Financ Manage. 2016 Mar;70(3):32-3.
6
Pharmaceuticals and Medical Devices: Medicare Part D.药品和医疗器械：医疗保险D部分
Issue Brief Health Policy Track Serv. 2016 Dec 27;2016:1-31.
7
Should drug prices be negotiated under part D of Medicare? And if so, how?医疗保险D部分下的药品价格应该进行谈判吗？如果应该，该如何进行谈判？
Health Aff (Millwood). 2008 Jan-Feb;27(1):33-43. doi: 10.1377/hlthaff.27.1.33.
8
Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025.预计将在 2025 年被纳入医疗保险药品价格谈判计划的药物。
J Manag Care Spec Pharm. 2024 Nov;30(11):1203-1210. doi: 10.18553/jmcp.2024.24167. Epub 2024 Sep 19.
9
The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?《降低通胀法案》：医疗保险药品价格谈判将如何影响心脏病患者？
Curr Cardiol Rep. 2023 Jun;25(6):577-581. doi: 10.1007/s11886-023-01878-7. Epub 2023 Apr 25.
10
Should drug prices be negotiated under part D?D部分的药品价格应该进行谈判吗？
Health Aff (Millwood). 2008 Jul-Aug;27(4):1197-8; author reply 1198. doi: 10.1377/hlthaff.27.4.1197-a.
引用本文的文献
1
Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025.预计将在 2025 年被纳入医疗保险药品价格谈判计划的药物。
J Manag Care Spec Pharm. 2024 Nov;30(11):1203-1210. doi: 10.18553/jmcp.2024.24167. Epub 2024 Sep 19.
Zotero 插件